Cargando…
Near-Term Anti-CD25 Monoclonal Antibody Administration Protects Murine Liver from Ischemia-Reperfusion Injury Due to Reduced Numbers of CD4(+) T Cells
BACKGROUND: CD4(+) T cell is acknowledged as a key factor in the initiation phase of liver ischemia reperfusion injury. The purpose of current study is to demonstrate the effect of antecedent near-term anti-CD25 monoclonal antibody treatment on IR-induced liver injury by modulation of CD4(+) T cells...
Autores principales: | Yang, Jinghui, Wang, Xiaoyu, Song, Shaohua, Liu, Fang, Fu, Zhiren, Wang, Quanxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154778/ https://www.ncbi.nlm.nih.gov/pubmed/25188007 http://dx.doi.org/10.1371/journal.pone.0106892 |
Ejemplares similares
-
CD44 Disruption Attenuates Murine Hepatic Ischemia/Reperfusion Injury
por: Kim, Min Sung, et al.
Publicado: (2011) -
Asiaticoside ameliorates renal ischemia/reperfusion injury by promoting CD4(+)CD25(+)FOXP3(+) treg cell differentiation
por: Tang, Shengjie, et al.
Publicado: (2023) -
Protective Effect of CXCR3(+)CD4(+)CD25(+)Foxp3(+) Regulatory T Cells in Renal Ischemia-Reperfusion Injury
por: Jun, Cao, et al.
Publicado: (2015) -
CD4(+)CD25(+)FOXP3(+) regulatory T cells: a potential “armor” to shield “transplanted allografts” in the war against ischemia reperfusion injury
por: Jeyamogan, Shareni, et al.
Publicado: (2023) -
Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model
por: Tan, Chunrui, et al.
Publicado: (2013)